Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2020 May 14

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Medica 2020 May 14

DOI: 10.23736/S0026-4806.20.06613-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

One-stage resection of primary colorectal cancer and hepatic metastases using the habib device: analysis of 40 consecutive cases treated in a unit of general surgery

Vincenzo TAMMARO 1 , Nicola CARLOMAGNO 1, Michele SANTANGELO 1, Armando CALOGERO 1, Concetta A. DODARO 1, Antonio VERNILLO 1, Antonello SICA 2, Gaia PELUSO 1, Silvia CAMPANILE 1, Evangelista SAGNELLI 3, Caterina SAGNELLI 3

1 Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy; 2 Department of Precision Medicine, University of Campania Campania Luigi Vanvitelli, Naples, Italy; 3 Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy


PDF


BACKGROUND: More than 50% of patients with Colorectal cancer (CRC) present or develop hepatic metastases (HM). The intraoperative use of the Habib 4X® radio frequency probe device is safe in resetting HM and allows a one-stage resection of both CRC and HM with a similar mortality rate than a two-stage surgical treatment.
METHODS: After an exhaustive residential training at the reference center for hepato-biliary surgery of the Imperial College of London, we treated at our unit of general surgery 40 consecutive patients with CRC and HM with the one-stage resection, using the Habib 4X® intraoperative radiofrequency probe device to reset HM.
RESULTS: None of the 40 patients died during the intra-operatory and post-operatory periods, none presented liver failures during the postoperative course nor complication related to the Habib’s resection procedure (e.g. bleeding, abscess, bile leak). The amount of intra-operative liver bleeding was minimal. New HM arose in 10 (25%) cases, with a mean disease-free interval of 13 months, but the hepatic tissue close to previous resections remained cancer-free. The 69.7 % of patients were disease-free at month 24 of the post-operative follow-up and 5-year rate was about 70%.
CONCLUSIONS: The data suggest that surgeons well trained at a reference center for hepato-biliary surgery may perform with excellent results the one-stage CRC and HM resection with the Habib 4X® device even in a unit of general surgery.


KEY WORDS: Colorectal cancer; Hepatic metastases; One stage resection; Habib 4x device

top of page